<SEC-DOCUMENT>0001437749-25-038563-index.html : 20251222
<SEC-HEADER>0001437749-25-038563.hdr.sgml : 20251222
<ACCEPTANCE-DATETIME>20251222171651
ACCESSION NUMBER:		0001437749-25-038563
CONFORMED SUBMISSION TYPE:	424B3
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20251222
DATE AS OF CHANGE:		20251222

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			NRX Pharmaceuticals, Inc.
		CENTRAL INDEX KEY:			0001719406
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				822844431
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-288205
		FILM NUMBER:		251593450

	BUSINESS ADDRESS:	
		STREET 1:		1201 ORANGE STREET
		STREET 2:		SUITE 600
		CITY:			WILMINGTON
		STATE:			DE
		ZIP:			19801
		BUSINESS PHONE:		484-254-6134

	MAIL ADDRESS:	
		STREET 1:		1201 ORANGE STREET
		STREET 2:		SUITE 600
		CITY:			WILMINGTON
		STATE:			DE
		ZIP:			19801

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Big Rock Partners Acquisition Corp.
		DATE OF NAME CHANGE:	20171012
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B3
<SEQUENCE>1
<FILENAME>nrxp20251219_424b3.htm
<DESCRIPTION>FORM 424B3
<TEXT>
Document 1 - file: nrxp20251219_424b3.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>nrx.jpg
<TEXT>
Document 2 - file: nrx.jpg

</DOCUMENT>
</SEC-DOCUMENT>